NST re­ports prompted ac­tion

New Straits Times - - News -

KUALA LUMPUR: The New Straits Times’ se­ries of exposé on the flour­ish­ing il­licit and dan­ger­ous busi­ness of “ozone ther­apy” prompted the au­thor­i­ties to tackle the is­sue once and for all.

The se­ries splashed on the NST’s front page for sev­eral days, prompt­ing many to come for­ward to the Health Min­istry to lodge com­plaints against beauty par­lours of­fer­ing such ser­vices.

They were among “vic­tims” who were lured by busi­ness op­er­a­tors driven solely by profit and had lit­tle re­gard for public safety and health.

Deputy Di­rec­tor-Gen­eral of Health (Med­i­cal) Datuk Dr S. Jeyain­dran told the NST that peo­ple had con­tacted the min­istry to share stories on the ad­verse ef­fects that they ex­pe­ri­enced after un­der­go­ing ozone ther­apy, fol­low­ing our exposé.

“We have re­ceived in­for­ma­tion on cases of com­pli­ca­tions and deaths as a re­sult of the in­tru­sive ses­sions.

“After read­ing the NST re­ports, many have called us. One of them was even pre­pared to come for­ward.”

He said the re­ports prompted sev­eral di­vi­sions un­der the min­istry to work to­gether to look for an am­i­ca­ble so­lu­tion for the mat­ter.

“We are thank­ful to the NST for high­light­ing this is­sue and work­ing with the min­istry to look deeper into it.

“Fol­low­ing that, sev­eral di­vi­sions un­der the min­istry, namely the Med­i­cal De­vice Author­ity (MDA), Na­tional Phar­ma­ceu­ti­cal Reg­u­la­tory Agency, Med­i­cal Prac­tice Di­vi­sion and sev­eral oth­ers, met to dis­cuss at length how we can reg­u­late the prac­tice.”

On the min­istry’s de­ci­sion to fi­nally ban the prac­tice, Dr Jeyain­dran said the min­istry had given op­er­a­tors am­ple time to prove the prac­tice’s “ef­fec­tive­ness” and get legalised by reg­is­ter­ing with the MDA.

“We had an­nounced on Jan 1 that we were giving them un­til mid-2017 to reg­is­ter, but none have come for­ward. Now, we hope they will vol­un­tar­ily with­draw from the mar­ket be­fore we start go­ing after them from July 1. “The with­drawal pe­riod is also what the USFDA (United States Food and Drug Ad­min­is­tra­tion) did when they de­cided to ban the prac­tice in the US.”

Datuk Dr S. Jeyain­dran

Newspapers in English

Newspapers from Malaysia

© PressReader. All rights reserved.